MiniMed Group is trading 4.39% down at $18.84, with no confirmed company announcement explaining the decline.
- Recent coverage noted record-high short interest; Jefferies initiated coverage with a Hold rating and a $22 target, but neither report establishes the cause.
- The October 9 Medtronic exchange-offer deadline and recent analyst actions are background, but reports do not show they caused the drop.
- Supplied market indicators are mixed, with no clear same-direction catalyst.